Boehringer Ingelheim Pharmaceuticals, Inc. Release: Colon Cancer Alliance and Dulcolax(R) Encourage Americans to Be a Lifesaver and Get Screened for Colon Cancer

RIDGEFIELD, Conn., March 1, 2012 /PRNewswire/ -- Every year, colon cancer takes the lives of tens of thousands of mothers, fathers, husbands, wives and friends, despite the fact that with an early screening, these deaths are highly preventable. This March during National Colorectal Cancer Awareness Month, the Colon Cancer Alliance (CCA) and makers of Dulcolax® are urging people to make an appointment with their doctor and schedule a colon cancer screening.

"While the idea of having a colonoscopy may not be appealing to everyone, a colonoscopy can be a lifesaver," said Andrew Spiegel, Chief Executive Officer of the Colon Cancer Alliance. "The impact of the consequences of not having one can be devastating to those most important to you. Whether you do it for yourself or for the ones you love, schedule a colonoscopy today."

Dulcolax® is continuing its partnership with the CCA for a second year in an effort to help increase awareness of colon cancer which, if found early enough, is one of the most treatable forms of cancer. Another goal of the partnership is to encourage early screenings which can truly be lifesavers. A portion of proceeds from the purchase of Dulcolax® products supports CCA community screening programs. To learn more about colon cancer and the importance of getting screened, visit and

About Colon Cancer
Colon cancer is the second leading cause of cancer death in the United States and affects men and women equally. If diagnosed early, colon cancer is highly preventable which is why screenings are a vital part of a healthy lifestyle. The majority of new cases occur in people ages 50 and older, yet about a third of Americans these ages have not been screened for the disease.

Colon cancer often shows no signs or symptoms, which is why getting a colonoscopy screening or talking to a loved one about getting screened can be a lifesaver against this highly preventable cancer. Men and woman over the age of 50 are being encouraged to take action this month and talk to their doctor to schedule a colonoscopy. Additionally, people with a family history of the disease or those who present other risk factors should get screened earlier.

About Dulcolax®
Dulcolax® products of Boehringer Ingelheim Pharmaceuticals, Inc.,have been a leader in constipation relief for over 50 years. Dulcolax® offers a range of solutions for relief from constipation, including Dulcolax® Laxative Tablets, Dulcolax® Laxative Suppositories and Dulcolax® Stool Softeners. A portion of the proceeds from every Dulcolax® purchase supports supports CCA community screening programs. For more information on the #1 doctor recommended stimulant for constipation relief, visit

About the Colon Cancer Alliance
The Colon Cancer Alliance (CCA) is the leading national patient advocacy organization dedicated to increasing colon cancer screening rates and survivorship. The CCA is an active, caring community that provides hope and support to patients and their families, while saving lives through screening, access, awareness, advocacy and research. For more information, please visit

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc. and Colon Cancer Alliance

Back to news